» Articles » PMID: 36795238

A Bibliometric Analysis and Visualization of Nonalcoholic Fatty Liver Disease from 2012 to 2021

Overview
Journal Clin Exp Med
Specialty General Medicine
Date 2023 Feb 16
PMID 36795238
Authors
Affiliations
Soon will be listed here.
Abstract

As a common chronic liver disease, nonalcoholic fatty liver disease (NAFLD) has attracted increasing attention in the past decade. Nevertheless, there are few bibliometric analyses that systematically study this field as a whole. This paper explores the latest research progress and future research trends of NAFLD through the method of bibliometric analysis. The articles related to NAFLD, published from 2012 to 2021 in the Web of Science Core Collections, were searched on February 21, 2022, using relevant keywords. Two different scientometrics software tools were used to conduct the knowledge maps of NAFLD research field. A total of 7975 articles on NAFLD research were included. From 2012 to 2021, the publications related to NAFLD increased by year. China ranked on the top of the list with 2043 publications, and the University of California System emerged as the premier institution in this field. PLOs One, Journal of Hepatology and Scientific Reports became the prolific journals in this research field. Co-cited reference analysis revealed the landmark literature in this research field. In terms of potential hotspots, the burst keywords analysis revealed that liver fibrosis stage, sarcopenia, and autophagy will become the focus of future NAFLD research. The annual output of the global publications in the field of NAFLD research showed a strong upward trend. Research in the field of NAFLD in China and America is more mature than in other countries. Classic literature lays the foundation for research, and multi-field studies provide the new development directions. And besides, fibrosis stage, sarcopenia and autophagy research are the hot spots and frontiers of this field.

Citing Articles

Bibliometric analysis of research developments in oral and maxillofacial neuralgia from 2004 to 2023.

Cai Y, Liu K, Xiang J, Zheng H, Zhang D, Wang Y Medicine (Baltimore). 2024; 103(50):e40715.

PMID: 39686494 PMC: 11651469. DOI: 10.1097/MD.0000000000040715.


Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysis.

Shakhshir M, Zyoud S World J Gastroenterol. 2024; 30(24):3106-3119.

PMID: 38983957 PMC: 11230064. DOI: 10.3748/wjg.v30.i24.3106.


An examination of global research trends for exploring the associations between the gut microbiota and nonalcoholic fatty liver disease through bibliometric and visualization analysis.

Zyoud S, Alalalmeh S, Hegazi O, Shakhshir M, Abushamma F, Al-Jabi S Gut Pathog. 2024; 16(1):31.

PMID: 38961453 PMC: 11223324. DOI: 10.1186/s13099-024-00624-w.


Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study.

Zyoud S, Hegazi O, Alalalmeh S, Shakhshir M, Abushamma F, Khilfeh S World J Hepatol. 2024; 16(6):951-965.

PMID: 38948442 PMC: 11212647. DOI: 10.4254/wjh.v16.i6.951.


Unveiling global research trends and hotspots on mitochondria in NAFLD from 2000 to 2023: A bibliometric analysis.

Hu J, Chen Z, Zhou Y, Li Y, Liu J, Mi Y Immun Inflamm Dis. 2024; 12(3):e1226.

PMID: 38533910 PMC: 10966917. DOI: 10.1002/iid3.1226.


References
1.
Powell E, Wong V, Rinella M . Non-alcoholic fatty liver disease. Lancet. 2021; 397(10290):2212-2224. DOI: 10.1016/S0140-6736(20)32511-3. View

2.
Targher G, Lonardo A, Byrne C . Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2017; 14(2):99-114. DOI: 10.1038/nrendo.2017.173. View

3.
Yki-Jarvinen H . Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014; 2(11):901-10. DOI: 10.1016/S2213-8587(14)70032-4. View

4.
Tilg H, Adolph T, Dudek M, Knolle P . Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nat Metab. 2021; 3(12):1596-1607. DOI: 10.1038/s42255-021-00501-9. View

5.
Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View